SummaryAvalere experts took a closer look at emerging oncology trends, innovative approaches to payment and delivery, and what these changes will mean for patient access.
Sophisticated treatment advancements will continue to evolve how oncology stakeholders define value and manage cancer care during and after COVID-19. Join Avalere experts as they take a closer look at emerging trends, innovative approaches to payment and delivery, and what these changes will mean for patient access.
- COVID-19 impacts on oncology care delivery, cost, and outcomes
- Oncology payment and delivery reform amid a public health emergency
- Managing and paying for emerging therapies and cancer combo regimens
- 2020 election implications for the future of oncology care
produces measurable results. Let's work together.